Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Apr 16;13(4):1323.
doi: 10.3390/nu13041323.

Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes

Anne Daly  1 , Wolfgang Högler  2 , Nicola Crabtree  1 , Nick Shaw  1 , Sharon Evans  1 , Alex Pinto  1 , Richard Jackson  3 , Boyd J Strauss  4   5 , Gisela Wilcox  4   6 , Júlio C Rocha  7   8 , Catherine Ashmore  1 , Anita MacDonald  1
Affiliations
Comparative Study

Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes

Anne Daly et al. Nutrients. .

Abstract

Protein quality and quantity are important factors in determining lean body (muscle) mass (LBM). In phenylketonuria (PKU), protein substitutes provide most of the nitrogen, either as amino acids (AA) or glycomacropeptide with supplementary amino acids (CGMP-AA). Body composition and growth are important indicators of long-term health. In a 3-year prospective study comparing the impact of AA and CGMP-AA on body composition and growth in PKU, 48 children were recruited. N = 19 (median age 11.1 years, range 5-15 years) took AA only, n = 16 (median age 7.3 years, range 5-15 years) took a combination of CGMP-AA and AA, (CGMP50) and 13 children (median age 9.2 years, range 5-16 years) took CGMP-AA only (CGMP100). A dual energy X-ray absorptiometry (DXA) scan at enrolment and 36 months measured LBM, % body fat (%BF) and fat mass (FM). Height was measured at enrolment, 12, 24 and 36 months. No correlation or statistically significant differences (after adjusting for age, gender, puberty and phenylalanine blood concentrations) were found between the three groups for LBM, %BF, FM and height. The change in height z scores, (AA 0, CGMP50 +0.4 and CGMP100 +0.7) showed a trend that children in the CGMP100 group were taller, had improved LBM with decreased FM and % BF but this was not statistically significant. There appeared to be no advantage of CGMP-AA compared to AA on body composition after 3-years of follow-up. Although statistically significant differences were not reached, a trend towards improved body composition was observed with CGMP-AA when it provided the entire protein substitute requirement.

Keywords: body composition; glycomacropeptide; phenylketonuria; protein substitute.

PubMed Disclaimer

Conflict of interest statement

A.D., research funding from Vitaflo International, financial support from Nutricia, Mevalia & Vitaflo International to attend study days and conferences. S.E., research funding from Nutricia, financial support from Nutricia & Vitaflo International to attend study days and conferences. A.P. has received an educational grant from Cambrooke Therapeutics and grants from Vitaflo International, Nutricia, Merck Serono, Biomarin and Mevalia to attend scientific meetings. C.A. received honoraria from Nutricia and Vitaflo International to attend study days and conferences. J.C.R. is a member of the European Nutritionist Expert Panel (Biomarin), the Advisory Board for Applied Pharma Research and Nutricia, and received honoraria as a speaker from APR, Merck Serono, Biomarin, Nutricia, Vitaflo, Cambrooke, PIAM and Lifediet. A.M. received research funding and honoraria from Nutricia, Vitaflo International & Merck Serono, and is a member of the European Nutrition Expert Panel (Merck Serono International), the Sapropterin Advisory Board (Merck Serono international) and the Advisory Board Element (Danone-Nutricia). The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Change in median height z score from baseline to 36 months in the amino acids (AA), GCMP100 and CGMP 50 groups. Legend: AA, amino acid; CGMP, glycomacropeptide; CGMP50, protein substitutes based on combined CGMP and AA; CGMP100, protein substitute based on CGMP only.
See this image and copyright information in PMC

References

    1. Abdullah A., Peeters A., de Courten M., Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studies. Diabetes Res. Clin. Pract. 2010;89:309–319. doi: 10.1016/j.diabres.2010.04.012. - DOI - PubMed
    1. Moreno L.A., Pineda I., Rodriguez G., Fleta J., Giner A., Juste M.G., Sarria A., Bueno M. Leptin and metabolic syndrome in obese and non-obese children. Horm. Metab. Res. 2002;34:394–399. doi: 10.1055/s-2002-33472. - DOI - PubMed
    1. Sarria A., Moreno L.A., Garcí-LIop L.A., Fleta J., Morellon M.P., Bueno M. Body mass index, triceps skinfold and waist circumference in screening for adiposity in male children and adolescents. Acta Paediatr. 2001;90:387–392. doi: 10.1080/080352501750126195. - DOI - PubMed
    1. Kelly D.A. Nutritional factors affecting growth before and after liver transplantation. Pediatr. Transpl. 1997;1:80–84. - PubMed
    1. Cole T.J., Freeman J.V., Preece M.A. Body mass index reference curves for the UK, 1990. Arch. Dis. Child. 1995;73:25–29. doi: 10.1136/adc.73.1.25. - DOI - PMC - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources